<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/E0B545B3-693C-4CB6-A4B6-A1C7CA8CBEEB/chart/price-vs-fair-value?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/E0B545B3-693C-4CB6-A4B6-A1C7CA8CBEEB/chart/price-vs-fair-value"/></p>
<p>納斯達克 GM:ULBI 1 年股價與公允價值</p>
<p>探索 Ultralife 的社區公允價值並選擇您的觀點</p>
<p><strong>Ultralife Corporation</strong>（納斯達克:ULBI）的股價在過去 30 天內大幅下跌了 25%，回吐了近期的許多漲幅。這 30 天的下跌為股東們帶來了艱難的一年，股價在此期間下跌了 37%。</p>
<p>即使在如此大幅的價格下跌之後，Ultralife 目前可能仍在發出非常悲觀的信號，市盈率（&#34;P/E&#34;）為 33.9 倍，因為美國幾乎一半的公司市盈率低於 18 倍，甚至低於 11 倍的市盈率也並不罕見。然而，市盈率可能因某種原因而相對較高，需要進一步調查以確定其合理性。</p>
<p>特朗普承諾要&#34;釋放&#34;美國的石油和天然氣，這 15 只美國股票的發展有望受益。</p>
<p>儘管市場最近經歷了盈利增長，但 Ultralife 的盈利卻出現了逆轉，這並不好。可能很多人預計悲觀的盈利表現會大幅恢復，這使得市盈率沒有崩潰。如果沒有，那麼現有股東可能會對股價的可行性感到極度緊張。</p>
<p>查看我們對 Ultralife 的最新分析</p>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/322457-pe-multiple-vs-industry-1-dark-2/1755432806495?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/322457-pe-multiple-vs-industry-1-dark-2/1755432806495"/></p>
<p>納斯達克 GM:ULBI 市盈率與行業比較 2025 年 8 月 17 日</p>
<p>如果您想了解分析師對未來的預測，您應該查看我們關於 Ultralife 的 <strong>免費</strong> 報告。</p>
<h2>Ultralife 是否有足夠的增長潛力？</h2>
<p>您唯一會真正感到舒適的情況是，當公司的增長有望明顯超越市場時，才會看到像 Ultralife 這樣陡峭的市盈率。</p>
<p>首先回顧一下，公司的每股收益增長去年並不令人興奮，出現了令人失望的 69% 的下降。不幸的是，這使得它回到了三年前的起點，在此期間每股收益的增長几乎不存在。因此，股東們可能對不穩定的中期增長率並不太滿意。</p>
<p>展望未來，唯一覆蓋該公司的分析師的估計顯示，預計明年的盈利將增長 306%。這顯然高於更廣泛市場的 15% 的增長預測。</p>
<p>考慮到這一點，Ultralife 的市盈率高於大多數其他公司是可以理解的。似乎大多數投資者都在期待這種強勁的未來增長，並願意為該股票支付更高的價格。</p>
<h2>Ultralife 市盈率的底線</h2>
<p>Ultralife 的股價可能已經回落，但其市盈率仍然高企。通常情況下，我們會警告在做出投資決策時不要過於依賴市盈率，儘管它可以揭示其他市場參與者對公司的看法。</p>
<p>正如我們所懷疑的，我們對 Ultralife 分析師預測的審查顯示，其優越的盈利前景正在推動其高市盈率。在這種情況下，投資者認為盈利惡化的潛力不足以證明較低的市盈率。在這種情況下，很難看到股價在不久的將來大幅下跌。</p>
<p>那麼其他風險呢？每家公司都有風險，我們發現了 <strong>1 個 Ultralife 的警告信號</strong>，您應該瞭解。</p>
<p>如果您對 Ultralife 的業務實力 <strong>不確定</strong>，為什麼不探索我們互動式的股票列表，尋找一些您可能錯過的具有良好商業基礎的其他公司呢？</p>

ULBI

<p>Ultralife Corporation（納斯達克代碼：ULBI）的股價在過去 30 天內下跌了 25%，導致年內累計下降了 37%。儘管出現這種下滑，該公司的高市盈率為 33.9 倍，表明投資者對未來盈利增長持樂觀態度，預計明年的增長率將達到 306%，遠高於市場平均水平的 15%。然而，該公司在過去一年中每股收益下降了 69%，引發了對其財務穩定性的擔憂。投資者保持謹慎，但對復甦仍抱有希望</p>

<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/E0B545B3-693C-4CB6-A4B6-A1C7CA8CBEEB/chart/price-vs-fair-value" alt="" original-src="https://images.simplywall.st/company/E0B545B3-693C-4CB6-A4B6-A1C7CA8CBEEB/chart/price-vs-fair-value"/></p>
<p>NasdaqGM:ULBI 1 Year Share Price vs Fair Value</p>
<div class="lb-trans"><p>納斯達克 GM:ULBI 1 年股價與公允價值</p>
</div><p>Explore Ultralife's Fair Values from the Community and select yours</p>
<div class="lb-trans"><p>探索 Ultralife 的社區公允價值並選擇您的觀點</p>
</div><p>The <strong>Ultralife Corporation</strong> (NASDAQ:ULBI) share price has softened a substantial 25% over the previous 30 days, handing back much of the gains the stock has made lately. The drop over the last 30 days has capped off a tough year for shareholders, with the share price down 37% in that time.</p>
<div class="lb-trans"><p><strong>Ultralife Corporation</strong>（納斯達克:ULBI）的股價在過去 30 天內大幅下跌了 25%，回吐了近期的許多漲幅。這 30 天的下跌為股東們帶來了艱難的一年，股價在此期間下跌了 37%。</p>
</div><p>Even after such a large drop in price, Ultralife may still be sending very bearish signals at the moment with a price-to-earnings (or &#34;P/E&#34;) ratio of 33.9x, since almost half of all companies in the United States have P/E ratios under 18x and even P/E's lower than 11x are not unusual. However, the P/E might be quite high for a reason and it requires further investigation to determine if it's justified.</p>
<div class="lb-trans"><p>即使在如此大幅的價格下跌之後，Ultralife 目前可能仍在發出非常悲觀的信號，市盈率（&#34;P/E&#34;）為 33.9 倍，因為美國幾乎一半的公司市盈率低於 18 倍，甚至低於 11 倍的市盈率也並不罕見。然而，市盈率可能因某種原因而相對較高，需要進一步調查以確定其合理性。</p>
</div><p>Trump has pledged to &#34;unleash&#34; American oil and gas and these 15 US stocks have developments that are poised to benefit.</p>
<div class="lb-trans"><p>特朗普承諾要&#34;釋放&#34;美國的石油和天然氣，這 15 只美國股票的發展有望受益。</p>
</div><p>While the market has experienced earnings growth lately, Ultralife's earnings have gone into reverse gear, which is not great. It might be that many expect the dour earnings performance to recover substantially, which has kept the P/E from collapsing. If not, then existing shareholders may be extremely nervous about the viability of the share price.</p>
<div class="lb-trans"><p>儘管市場最近經歷了盈利增長，但 Ultralife 的盈利卻出現了逆轉，這並不好。可能很多人預計悲觀的盈利表現會大幅恢復，這使得市盈率沒有崩潰。如果沒有，那麼現有股東可能會對股價的可行性感到極度緊張。</p>
</div><p>Check out our latest analysis for Ultralife</p>
<div class="lb-trans"><p>查看我們對 Ultralife 的最新分析</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/322457-pe-multiple-vs-industry-1-dark-2/1755432806495" alt="" original-src="https://images.simplywall.st/asset/chart/322457-pe-multiple-vs-industry-1-dark-2/1755432806495"/></p>
<p>NasdaqGM:ULBI Price to Earnings Ratio vs Industry August 17th 2025</p>
<div class="lb-trans"><p>納斯達克 GM:ULBI 市盈率與行業比較 2025 年 8 月 17 日</p>
</div><p>If you'd like to see what analysts are forecasting going forward, you should check out our <strong>free</strong> report on Ultralife.</p>
<div class="lb-trans"><p>如果您想了解分析師對未來的預測，您應該查看我們關於 Ultralife 的 <strong>免費</strong> 報告。</p>
</div><h2>Is There Enough Growth For Ultralife?</h2>
<div class="lb-trans"><h2>Ultralife 是否有足夠的增長潛力？</h2>
</div><p>The only time you'd be truly comfortable seeing a P/E as steep as Ultralife's is when the company's growth is on track to outshine the market decidedly.</p>
<div class="lb-trans"><p>您唯一會真正感到舒適的情況是，當公司的增長有望明顯超越市場時，才會看到像 Ultralife 這樣陡峭的市盈率。</p>
</div><p>Taking a look back first, the company's earnings per share growth last year wasn't something to get excited about as it posted a disappointing decline of 69%. Unfortunately, that's brought it right back to where it started three years ago with EPS growth being virtually non-existent overall during that time. Accordingly, shareholders probably wouldn't have been overly satisfied with the unstable medium-term growth rates.</p>
<div class="lb-trans"><p>首先回顧一下，公司的每股收益增長去年並不令人興奮，出現了令人失望的 69% 的下降。不幸的是，這使得它回到了三年前的起點，在此期間每股收益的增長几乎不存在。因此，股東們可能對不穩定的中期增長率並不太滿意。</p>
</div><p>Shifting to the future, estimates from the sole analyst covering the company suggest earnings should grow by 306% over the next year. That's shaping up to be materially higher than the 15% growth forecast for the broader market.</p>
<div class="lb-trans"><p>展望未來，唯一覆蓋該公司的分析師的估計顯示，預計明年的盈利將增長 306%。這顯然高於更廣泛市場的 15% 的增長預測。</p>
</div><p>In light of this, it's understandable that Ultralife's P/E sits above the majority of other companies. It seems most investors are expecting this strong future growth and are willing to pay more for the stock.</p>
<div class="lb-trans"><p>考慮到這一點，Ultralife 的市盈率高於大多數其他公司是可以理解的。似乎大多數投資者都在期待這種強勁的未來增長，並願意為該股票支付更高的價格。</p>
</div><h2>The Bottom Line On Ultralife's P/E</h2>
<div class="lb-trans"><h2>Ultralife 市盈率的底線</h2>
</div><p>Ultralife's shares may have retreated, but its P/E is still flying high. Typically, we'd caution against reading too much into price-to-earnings ratios when settling on investment decisions, though it can reveal plenty about what other market participants think about the company.</p>
<div class="lb-trans"><p>Ultralife 的股價可能已經回落，但其市盈率仍然高企。通常情況下，我們會警告在做出投資決策時不要過於依賴市盈率，儘管它可以揭示其他市場參與者對公司的看法。</p>
</div><p>As we suspected, our examination of Ultralife's analyst forecasts revealed that its superior earnings outlook is contributing to its high P/E. At this stage investors feel the potential for a deterioration in earnings isn't great enough to justify a lower P/E ratio. It's hard to see the share price falling strongly in the near future under these circumstances.</p>
<div class="lb-trans"><p>正如我們所懷疑的，我們對 Ultralife 分析師預測的審查顯示，其優越的盈利前景正在推動其高市盈率。在這種情況下，投資者認為盈利惡化的潛力不足以證明較低的市盈率。在這種情況下，很難看到股價在不久的將來大幅下跌。</p>
</div><p>And what about other risks? Every company has them, and we've spotted <strong>1 warning sign for Ultralife</strong> you should know about.</p>
<div class="lb-trans"><p>那麼其他風險呢？每家公司都有風險，我們發現了 <strong>1 個 Ultralife 的警告信號</strong>，您應該瞭解。</p>
</div><p>If you're <strong>unsure about the strength of Ultralife's business</strong>, why not explore our interactive list of stocks with solid business fundamentals for some other companies you may have missed.</p>
<div class="lb-trans"><p>如果您對 Ultralife 的業務實力 <strong>不確定</strong>，為什麼不探索我們互動式的股票列表，尋找一些您可能錯過的具有良好商業基礎的其他公司呢？</p>
</div>

儘管 Ultralife Corporation（NASDAQ:ULBI）的股價下跌了 25%，但仍然與投資者的看法一致